Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters

PURPOSE: Keyhole limpet hemocyanin (KLH) attracts biomedical interest because of its remarkable immunostimulatory properties. Currently, KLH is used as vaccine adjuvant, carrier protein for haptens and as local treatment for bladder cancer. Since a quantitative human anti-KLH assay is lacking, it ha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Aarntzen, Erik H. J. G., de Vries, I. Jolanda M., Göertz, Joop H., Beldhuis-Valkis, Marjo, Brouwers, Huberdina M. L. M., van de Rakt, Mandy W. M. M., van der Molen, Renate G., Punt, Cornelis J. A., Adema, Gosse J., Tacken, Paul J., Joosten, Irma, Jacobs, Joannes F. M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2012
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3493659/
https://ncbi.nlm.nih.gov/pubmed/22527252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-012-1263-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados